Answer
Riluzole is proposed to inhibit glutamate processes in ALS, although its mode of action is unclear.
Sources for this answer
- Riluzole 50 mg film-coated tabletsRanbaxy (UK) Limited a Sun Pharmaceutical Company · emc · SmPC §5.1 Pharmacodynamic properties · Version 8Document updated
Sources checked